Get the Stockscreener App
70.27
1.87%
-1.34
Pre-market:
70.27
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $70.27, with a volume of 3.37M.
It is down -1.87% in the last 24 hours and down -8.94% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$71.61
Open:
$71.85
24h Volume:
3.37M
Relative Volume:
0.58
Market Cap:
$29.04B
Revenue:
$9.51B
Net Income/Loss:
$2.64B
P/E Ratio:
11.64
EPS:
6.0361
Net Cash Flow:
$2.14B
1W Performance:
-3.77%
1M Performance:
-8.94%
6M Performance:
-39.39%
1Y Performance:
-50.40%
1-Day Range:
$69.93
$72.38
1-Week Range:
$69.93
$73.55
52-Week Range:
$69.93
$148.79
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
70.27 | 29.04B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
18.59 | 59.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
40.22 | 46.91B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
472.21 | 20.25B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis (NYSE:ZTS) Looks Like a Decent Value Stock - ChartMill
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance UK
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Trading the Move, Not the Narrative: (ZTS) Edition - Stock Traders Daily
Zoetis sets Nov 5 webcast for Q3FY26 earnings review - scanx.trade
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results - Business Wire
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis stock falls as TD Cowen cuts its target - AD HOC NEWS
Zoetis stock hits 52-week low at 70.97 USD - Investing.com
Zoetis Inc. (ZTS) Stock Analysis: Exploring A 34% Potential Upside For Investors - DirectorsTalk Interviews
The Best Healthcare Stocks to Buy - Morningstar
Zoetis Director Mark Stetter Acquires 342 Phantom Stock Units Under Deferred Compensation Plan - Kalkine Media
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note - finance.yahoo.com
Zoetis Stock: The Worst May Be Priced In (NYSE:ZTS) - Seeking Alpha
Stifel reiterates Zoetis stock rating at Hold on share concerns - Investing.com
Why this money manager bought UnitedHealth, Palantir and sold Zoetis - The Globe and Mail
Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales - TradingView
Zoetis: Companion Animal Weakness Keeps Me On The Sidelines (NYSE:ZTS) - Seeking Alpha
Zoetis: An Undervalued Compounder Hiding In Plain Sight (NYSE:ZTS) - Seeking Alpha
Zoetis Stock: New Competition Changes The Story, But Not Yet The Rating (NYSE:ZTS) - Seeking Alpha
Zoetis Introduces Blood Parasite Detection and Enhanced Cell Classification to Vetscan Imagyst | Vet Candy News - Vet Candy
Zoetis Inc. (ZTS) - DirectorsTalk Interviews
Zoetis (NYSE:ZTS): A Quality Dividend Stock for Dividend Investors - ChartMill
Michael Burry Sells FLUT To Pile Into LULU Under $100 — Plus A New Bet On ZTS - TradingView
Why Are Zoetis (NYSE:ZTS) Diagnostics in S&P 500 Focus? - Kalkine Media
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? - Yahoo Finance
Zoetis Shares Slide Following Earnings RevisionEarnings Deceleration Risk - vinanet.vn
Zoetis Stock (ZTS) Opinions on Michael Burry Portfolio Update - Moomoo
Zoetis Taps Former GE HealthCare CFO Jay Saccaro as CFO and COO - The Healthcare Technology Report.
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Paws and profits: Zoetis appoints global diagnostics president, NVA names chief medical officer, and more updates - DVM360
Zoetis (ZTS) Shares Drop After Earnings Revision - Yahoo Finance
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Is Zoetis Stock Underperforming the S&P 500? - Yahoo Finance
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - BioSpace
Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package - ChartMill
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Is It Too Late to Buy Zoetis Inc (ZTS) After 3.1% Rally? GF Value Says Undervalued - GuruFocus
A Look at Zoetis Inc (ZTS) After 3.2% Decline -- GF Value $180.6 - GuruFocus
The Bull Case For Zoetis (ZTS) Could Change Following FDA Emergency Use Authorization For Simparica Trio - simplywall.st
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? - finance.yahoo.com
MS Global Franchise Portfolio's Bold Q2 2026 Move: Exits Zoetis Inc, a -2.6% Portfolio Impact - Yahoo Finance
Zoetis Inc. $ZTS Shares Acquired by Wealthfront Advisers LLC - MarketBeat
Zoetis Updates Prescribing Information for FACTREL Cattle Injection - geneonline.com
ZTS Maintained by Stifel -- Price Target Lowered to $80 - GuruFocus
Stifel Nicolaus Has Lowered Expectations for Zoetis (NYSE:ZTS) Stock Price - MarketBeat
Stifel cuts Zoetis stock price target on key franchise weakness - Investing.com
Stifel cuts Zoetis stock price target on key franchise weakness By Investing.com - Investing.com India
Meeder Asset Management Inc. Sells 42,497 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.52%
1.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):